University of Cologne | MedPath Search

Clinical Trials

Find the latest clinical trials by condition, location & phase

Browse and search for drug information and related clinical trials

Explore a comprehensive list of organizations, including their profiles and details.

Latest updates on clinical trials, pharmaceuticals, and healthcare companies

DeepMed Research

|

Filters

Study Phase

Early Phase 1

Phase 1

Phase 1/2

Phase 2

Phase 2/3

Phase 3

Phase 4

Not Applicable

Recruitment Status

Recruiting

Not yet recruiting

Active, not recruiting

Completed

Suspended

Terminated

Withdrawn

Study Type

Interventional

Observational

Expanded Access

Others

Eligibility Sex

All

Female

Male

Healthy Volunteers

All

Include

Exclude

Found 407 clinical trials|View Analysis

Sort by:

Need a comprehensive medical report on "University of Cologne"?

Analyze the latest clinical research and treatment options

Summarize scientific findings from medical journals

Ofatumumab in Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL)

Phase 2

Completed

Conditions: Relapsed NLPHL

First Posted Date: 2010-08-24

Last Posted Date: 2015-11-01

Lead Sponsor: University of Cologne

Target Recruit Count: 28

Registration Number: NCT01187303

Locations: 🇩🇪
1st Department of Medicine, Cologne University Hospital, Cologne, Germany

Comparison of Endotracheal Intubation Success Rates Using Video Laryngoscopes in Entrapped Patients - a Manikin Study

Completed

Conditions: Endotracheal Intubation

First Posted Date: 2010-08-17

Last Posted Date: 2010-11-11

Lead Sponsor: University of Cologne

Target Recruit Count: 30

Registration Number: NCT01182740

Locations: 🇩🇪
University Hospital of Cologne, Cologne, Germany

Comparative Study of Ologen Collagen Matrix Versus Mitomycin-C in Trabeculectomy: A Study in Germany

Not Applicable

Conditions: Open-angle Glaucoma

Interventions: Device: Use of ologen Collagen Matrix in trabeculectomy
Drug: Use of Mitomycin-C in trabeculectomy

First Posted Date: 2010-08-03

Last Posted Date: 2011-05-09

Lead Sponsor: Aeon Astron Europe B.V.

Target Recruit Count: 40

Registration Number: NCT01174420

Locations: 🇩🇪
The University Hospital of Cologne, Cologne, Germany

Canthaxanthin Retinopathy: A Long-term Observation

Completed

Conditions: Canthaxanthin Retinopathy

First Posted Date: 2010-05-21

Last Posted Date: 2010-05-21

Lead Sponsor: University of Cologne

Target Recruit Count: 35

Registration Number: NCT01128062

Locations: 🇩🇪
University Eye Hospital, University of Cologne, Cologne, NRW, Germany

The Influence of Anterior Chamber Fluid Mediators on the Success Rate of Trabeculectomy

Completed

Conditions: Wound Healing
Glaucoma
Trabeculectomy

Interventions: Procedure: Trabeculectomy

First Posted Date: 2010-05-04

Last Posted Date: 2018-11-20

Lead Sponsor: University of Cologne

Target Recruit Count: 62

Registration Number: NCT01115218

Locations: 🇩🇪
University Eye Hospital, University of Cologne, Cologne, NRW, Germany

Blephacura Versus Baby Shampoo to Treat Blepharitis

Not Applicable

Completed

Conditions: Blepharitis

Interventions: Procedure: Group B
Procedure: Group A

First Posted Date: 2010-05-04

Last Posted Date: 2018-11-19

Lead Sponsor: University of Cologne

Target Recruit Count: 144

Registration Number: NCT01115192

Locations: 🇩🇪
University Eye Hospital, University of Cologne, Cologne, NRW, Germany

Effects of Clopidogrel on Blood Pressure

Phase 4

Completed

Conditions: Blood Pressure
Endothelial Function
Platelet Function

Interventions: Drug: Clopidogrel

First Posted Date: 2010-04-28

Last Posted Date: 2010-04-28

Lead Sponsor: University of Cologne

Target Recruit Count: 46

Registration Number: NCT01112137

Locations: 🇩🇪
University of Cologne, Cologne, Germany
🇳🇱
St Antonius Hospital Nieuwegein, Nieuwegein, Netherlands

Safety and Efficacy of COBI-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

Phase 3

Completed

Conditions: HIV
HIV Infections

Interventions: Drug: COBI
Drug: RTV
Drug: ATV
Drug: FTC/TDF
Drug: COBI placebo
Drug: RTV placebo

First Posted Date: 2010-04-22

Last Posted Date: 2016-05-23

Lead Sponsor: Gilead Sciences

Target Recruit Count: 698

Registration Number: NCT01108510

Locations: 🇺🇸
Kaiser Permanente, Los Angeles, California, United States
🇺🇸
Oasis Clinic, Los Angeles, California, United States
🇺🇸
Peter J Ruane, MD, Inc, Los Angeles, California, United States

and more 131 locations

Study to Evaluate the Safety and Efficacy of Stribild Versus Ritonavir-Boosted Atazanavir Plus Truvada in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults

Phase 3

Completed

Conditions: HIV
HIV Infections

Interventions: Drug: Stribild
Drug: ATV
Drug: ATV Placebo
Drug: Ritonavir
Drug: RTV Placebo
Drug: FTC/TDF
Drug: FTC/TDF Placebo
Drug: Stribild Placebo

First Posted Date: 2010-04-20

Last Posted Date: 2015-11-11

Lead Sponsor: Gilead Sciences

Target Recruit Count: 708

Registration Number: NCT01106586

Locations: 🇺🇸
Kaiser Permanente, Los Angeles, California, United States
🇺🇸
Ruth M. Rothstein CORE Center, Chicago, Illinois, United States
🇺🇸
The Stamford Hospital, Stamford, Connecticut, United States

and more 143 locations

A Phase 3 Study of Brentuximab Vedotin (SGN-35) in Patients at High Risk of Residual Hodgkin Lymphoma Following Stem Cell Transplant (The AETHERA Trial)

Phase 3

Completed

Conditions: Disease, Hodgkin

Interventions: Drug: placebo
Drug: brentuximab vedotin

First Posted Date: 2010-04-09

Last Posted Date: 2021-05-14

Lead Sponsor: Seagen Inc.

Target Recruit Count: 329

Registration Number: NCT01100502

Locations: 🇺🇸
Cardinal Bernardin Cancer Center / Loyola University Medical Center, Maywood, Illinois, United States
🇺🇸
Cleveland Clinic, The, Cleveland, Ohio, United States
🇺🇸
Western Pennsylvania Cancer Institute, Pittsburgh, Pennsylvania, United States

and more 84 locations

Prev
1
29
30
31
32
33
41
Next

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy